Singapore markets closed
Straits Times Index
3,415.51 +47.61 (+1.41%) S&P 500
5,509.01 +33.92 (+0.62%) Dow
39,331.85 +162.33 (+0.41%) Nasdaq
18,028.76 +149.46 (+0.84%) Bitcoin USD
60,497.86 -2,071.01 (-3.31%) CMC Crypto 200
1,304.39 -30.53 (-2.29%)
Oxford Biomedica plc (OXB.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 10:26AM BST. Market open.
| Previous close | 309.00 |
| Open | 312.00 |
| Bid | 305.00 x 0 |
| Ask | 308.00 x 0 |
| Day's range | 301.00 - 312.00 |
| 52-week range | 164.29 - 460.00 |
| Volume | |
| Avg. volume | 246,747 |
| Market cap | 324.339M |
| Beta (5Y monthly) | 1.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.63 |
| Earnings date | 18 Sept 2024 - 23 Sept 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 448.88 |
Simply Wall St.Oxford Biomedica plc (LON:OXB) is favoured by institutional owners who hold 53% of the company
Key Insights Significantly high institutional ownership implies Oxford Biomedica's stock price is sensitive to their...
- Simply Wall St.
Oxford Biomedica (LON:OXB) investors are sitting on a loss of 71% if they invested three years ago
Oxford Biomedica plc ( LON:OXB ) shareholders will doubtless be very grateful to see the share price up 89% in the last...
Simply Wall St.Oxford Biomedica Full Year 2023 Earnings: Misses Expectations
Oxford Biomedica ( LON:OXB ) Full Year 2023 Results Key Financial Results Revenue: UK£89.5m (down 36% from FY 2022...
© 2024 Yahoo. All rights reserved.